title: p14ARF, p15INK4b, and p16INK4a methylation status in chronic myelogenous leukemia.
authors.forename: Sophie
authors.initials: S
authors.lastname: Kusy
authors.forename: Marie
authors.initials: M
authors.lastname: Cividin
authors.forename: Nathalie
authors.initials: N
authors.lastname: Sorel
authors.forename: Françoise
authors.initials: F
authors.lastname: Brizard
authors.forename: François
authors.initials: F
authors.lastname: Guilhot
authors.forename: André
authors.initials: A
authors.lastname: Brizard
authors.forename: Christian
authors.initials: C
authors.lastname: Larsen
authors.forename: Joëlle
authors.initials: J
authors.lastname: Roche
mesh_terms: D018797:Cell Cycle Proteins / Q000235:genetics*; D050762:Cyclin-Dependent Kinase Inhibitor p15; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics; D019175:DNA Methylation; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics*; D011401:Promoter Regions, Genetic; D025803:Tumor Suppressor Protein p14ARF / Q000235:genetics; D025521:Tumor Suppressor Proteins
chemical_list: C493966:CDKN2B protein, human; D018797:Cell Cycle Proteins; D050762:Cyclin-Dependent Kinase Inhibitor p15; D019941:Cyclin-Dependent Kinase Inhibitor p16; D025803:Tumor Suppressor Protein p14ARF; D025521:Tumor Suppressor Proteins